COMP <GO>
IDXG vs NUR // PIOTROSKI F-SCORE QUALITY
Interpace Biosciences Inc. (NASDAQ) VS. Nuran Wireless Inc. (NASDAQ) • 15-METRIC TALLY: IDXG 2
— NUR 0
■ METRIC PARITY
LAST: $5.72 (+15.56%) • MKT CAP: $23.2M
piotroski-score
6/9
LAST: $0.68 (+0.95%) • MKT CAP: $9.0M
piotroski-score
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IDXG VS. NUR)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | IDXG | NUR | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 62.30% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 16.20% | — | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | 4.7x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 23.60% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | 10.50% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | 63.50% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | -17.50% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 6/9 | — | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 50.0 | 31.8 | +18.13 | IDXG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $23.2M | $9.0M | $14.2M | IDXG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | IDXG REV | NUR REV | IDXG GROSS % | NUR GROSS % | IDXG FCF | NUR FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $38.7M | — | 62.3% | — | $5.5M | — |
| FY 2024 | $46.9M | — | 63.8% | — | $3.8M | — |
| FY 2023 | $40.0M | — | — | — | $3.8M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IDXG // BETA —
NUR // BETA —